Hypovascular hepatic nodule showing hypointensity in the hepatobiliary phase of gadoxetic acid-enhanced MRI in patients with chronic liver disease: Prediction of malignant transformation

European Journal of Radiology

Volumn 81, Issue 11, 2012, Pages 3072-3078

  Takayama, Yukihisa ^a   Nishie, Akihiro ^a   Nakayama, Tomohiro ^a   Asayama, Yoshiki ^a   Ishigami, Kousei ^a   Kakihara, Daisuke ^a   Ushijima, Yasuhiro ^a   Fujita, Nobuhiro ^a   Hirakawa, Masakazu ^b   Honda, Hiroshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY BEPPU HOSPITAL   (Japan)

Author keywords

Gadoxetic acid; Gd EOB DTPA; Hepatocarcinogenesis; Hepatocellular carcinoma; Hypovascular hepatic nodule; Magnetic resonance imaging

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA FETOPROTEIN; GADOXETIC ACID; IODINATED CONTRAST MEDIUM; IOHEXOL; IOPAMILON 370; UNCLASSIFIED DRUG;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; HYPOVASCULAR HEPATIC NODULE; IMAGE ANALYSIS; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER NODULE; LIVER SIZE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; VASCULARIZATION;

AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84866990088     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2012.05.008     Document Type: Article

References (20)

1. M. Kudo, K.H. Han, and N. Kokudo Liver Cancer Working Group report Japanese Journal of Clinical Oncology 40 Suppl. 1 2010 i19 i27
2. M. Kudo Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma? Oncology 78 Suppl. 1 2010 87 93
3. T.J. Vogl, S. Kümmel, and R. Hammerstingl Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA Radiology 200 1 1996 59 67
4. H. Akai, S. Kiryu, and I. Matsuda Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row CT European Journal of Radiology 80 2 2011 310 315
5. A. Tanimoto, J.M. Lee, T. Murakami, A. Huppertz, M. Kudo, and L. Grazioli Consensus report of the 2nd International Forum for Liver MRI European Radiology 19 Suppl. 5 2009 S975 S989
6. K. Shinozaki, K. Yoshimitsu, and H. Irie Comparison of test-injection method and fixed-time method for depiction of hepatocellular carcinoma using dynamic steady-state free precession magnetic resonance imaging Journal of Computer Assisted Tomography 28 5 2004 628 634
7. R. Tateishi, and K. Koike Identification of high-risk group for hepatocellular carcinoma Hepato-Biliary-Pancreatic Imaging 21 2010 167 172
8. T. Kumada, H. Toyoda, and T. Tada Evolution of hypointense hepatocellular nodules observed only in the hepatobiliary phase of gadoxetate disodium-enhanced MRI American Journal of Roentgenology 197 1 2011 58 63
9. U. Motosugi, T. Ichikawa, and K. Sano Outcome of hypovascular hepatic nodules revealing no gadoxetic acid uptake in patients with chronic liver disease Journal of Magnetic Resonance Imaging 34 1 2011 88 94
10. J.H. Lim, D. Choi, and S.H. Kim Detection of hepatocellular carcinoma: value of adding delayed phase imaging to dual-phase helical CT American Journal of Roentgenology 179 1 2002 Jul 67 73
11. S. Monzawa, T. Ichikawa, H. Nakajima, Y. Kitanaka, K. Omata, and T. Araki Dynamic CT for detecting small hepatocellular carcinoma: usefulness of delayed phase imaging American Journal of Roentgenology 188 1 2007 147 153
12. E. Quaia, V. Alaimo, and E. Baratella The added diagnostic value of 64-row multidetector CT combined with contrast-enhanced US in the evaluation of hepatocellular nodule vascularity: implications in the diagnosis of malignancy in patients with liver cirrhosis European Radiology 19 3 2009 651 663
13. M.K. Seale, O.A. Catalano, S. Saini, P.F. Hahn, and D.V. Sahani Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree Radiographics 29 6 2009 1725 1748
14. M. Kudo, N. Izumi, and N. Kokudo Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version Digestive Diseases 29 3 2011 339 364
15. M. Sakamoto, S. Hirohashi, and Y. Shimosato Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma Human Pathology 22 2 1991 172 178
16. M. Kudo Multistep human hepatocarcinogenesis: correlation of imaging with pathology Journal of Gastroenterology 44 Suppl. XIX 2009 112 118
17. K. Taguchi, S. Aishima, and S. Matsuura Significance of the relationship between irregular regeneration and two hepatocarcinogenic pathways: "De Novo" and so-called "Dysplastic Nodule-Hepatocellular Carcinoma" sequence Journal of Surgical Oncology 92 November (2) 2005 100 103
18. M. Hayashi, O. Matsui, and K. Ueda Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium American Journal of Roentgenology 172 4 1999 969 976
19. C.J. Chen, H.I. Yang, and J. Su Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level JAMA 295 1 2006 65 73
20. M.H. Lee, H.I. Yang, and C.L. Jen Community and personal risk factors for hepatitis C virus infection: a survey of 23,820 residents in Taiwan in 1991-2 Gut 60 5 2011 688 694